Skip to content

    Arcturus Therapeutics Holdings (ARCT) stock price & financials

    View ARCT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance12.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $41.67M
    $22.77M
    $29.38M
    $28.30M
    $17.15M
    -58.8%
    $7.20M
    -68.4%
    $2.06M
    -93.0%
    $2.96M
    -89.5%
    Weakening
    Operating Profit
    -$10.74M
    -$33.39M
    -$16.83M
    -$11.62M
    -$16.51M
    -53.8%
    -$31.31M
    +6.3%
    -$28.93M
    -71.9%
    -$25.55M
    -119.9%
    Weakening
    Net Profit
    -$6.90M
    -$30.00M
    -$14.08M
    -$9.18M
    -$13.45M
    -94.8%
    -$29.08M
    +3.1%
    -$26.96M
    -91.6%
    -$23.79M
    -159.1%
    Weakening
    EPS
    $-0.26
    $-0.52
    $-0.34
    $-0.49
    -88.5%
    $-0.95
    -82.7%
    $-0.84
    -147.1%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$7.12M
    $131.99M
    -$14.08M
    -$9.18M
    -$13.45M
    -88.9%
    -$29.08M
    -122.0%
    -$23.79M
    -159.2%
    Weakening
    MarginsOPM
    -25.8%
    -146.7%
    -57.3%
    -41.0%
    -96.3%
    -273.7%
    -435.0%
    -196.6%
    -1403.7%
    -2351.1%
    -863.3%
    -2003.6%
    Weakening
    Tax
    3.0%
    0.0%
    0.0%
    -0.0%
    0.0%
    +100.0%
    Strengthening
    ReturnsROIC
    1.2%
    5.3%
    2.5%
    1.6%
    2.4%
    +94.8%
    5.1%
    -3.1%
    4.8%
    +91.6%
    4.2%
    +159.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$36.71M$71.35M$462.89M$370.49M$391.88M$292.00M$237.03M$230.91M$191.48M
    Short-Term Investments
    Total Current Assets$41.83M$74.29M$467.79M$378.96M$403.33M$386.59M$305.98M$241.45M$197.16M
    Net PP&E$1.98M$7.48M$8.56M$11.26M$44.96M$40.93M$36.20M$27.82M$25.12M
    Goodwill
    Intangibles
    Total Assets$44.20M$82.14M$476.46M$392.81M$450.39M$429.40M$344.07M$271.15M$224.31M
    LiabilitiesTotal Current Liabilities$12.58M$21.32M$49.52M$99.54M$126.98M$81.99M$65.49M$36.38M$33.54M
    Short-Term Debt$1.25M$22.47M$60.66M
    Long-Term Debt$9.91M$14.99M$13.85M$40.63M
    Long-Term Leases$4.85M$4.03M$4.50M$30.22M$25.91M$25.00M$20.78M$18.97M
    Total Liabilities$30.56M$56.35M$79.90M$164.60M$180.07M$150.89M$103.09M$57.16M$52.50M
    EquityCommon Stock & APIC$214.0K$15.0K$26.0K$26.0K$27.0K$27.0K$27.0K$28.0K$28.0K
    Retained Earnings-$44.87M-$71.67M-$143.82M-$347.49M-$338.14M-$367.87M-$448.81M-$514.59M-$565.34M
    Total Equity$13.64M$25.79M$396.55M$228.21M$270.31M$278.51M$240.98M$213.99M$171.81M
    HighlightsNet Cash / (Debt)$447.80M$307.38M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$20.76M-$6.45M-$42.86M-$135.04M$31.99M-$18.10M-$59.75M-$74.27M-$72.73M
    Cash from Investing$22.13M-$818.0K-$1.74M-$3.41M-$7.73M-$2.90M-$648.0K-$230.0K-$41.0K
    Cash from Financing$10.20M$41.91M$436.14M$48.02M-$2.86M-$24.09M$5.42M$13.38M$12.93M
    SummaryCapital Expenditure-$1.48M-$818.0K-$1.74M-$3.41M-$7.73M-$2.90M-$648.0K-$230.0K-$93.0K
    Free Cash Flow-$22.24M-$7.26M-$44.60M-$138.45M$24.27M-$21.00M-$60.40M-$74.50M-$72.82M
    FCF Margin-141.2%-34.9%-467.6%-1120.2%11.8%-12.6%-39.7%-90.8%-248.0%

    Ratios